ArticleBioengineering & translational medicine2023

Preclinical assessment of IRDye800CW-labeled gastrin-releasing peptide receptor-targeting peptide for near infrared-II imaging of brain malignancies.

Yuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.